Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2004

Open Access 01-12-2004 | Research article

The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome

Authors: Demosthenes Bouros, Michael G Alexandrakis, Katerina M Antoniou, Panagiotis Agouridakis, Ioannis Pneumatikos, Stavros Anevlavis, Athanasia Pataka, George Patlakas, Nikolaos Karkavitsas, Despina Kyriakou

Published in: BMC Pulmonary Medicine | Issue 1/2004

Login to get access

Abstract

Background

The predictive role of many cytokines has not been well defined in Acute Respiratory Distress Syndrome (ARDS).

Methods

We measured prospectively IL-4, IL-6, IL-6 receptor, IL-8, and IL-10, in the serum and bronchoalveolar lavage fluid (BALF) in 59 patients who were admitted to ICU in order to identify predictive factors for the course and outcome of ARDS. The patients were divided into three groups: those fulfilling the criteria for ARDS (n = 20, group A), those at risk for ARDS and developed ARDS within 48 hours (n = 12, group B), and those at risk for ARDS but never developed ARDS (n = 27, group C).

Results

An excellent negative predictive value for ARDS development was found for IL-6 in BALF and serum (100% and 95%, respectively). IL-8 in BALF and IL-8 and IL-10 serum levels were higher in non-survivors in all studied groups, and were associated with a high negative predictive value. A significant correlation was found between IL-8 and APACHE score (r = 0.60, p < 0.0001). Similarly, IL-6 and IL-6r were highly correlated with PaO2/FiO2 (r = -0.27, p < 0.05 and r = -0.55, p < 0.0001, respectively).

Conclusions

BALF and serum levels of the studied cytokines on admission may provide valuable information for ARDS development in patients at risk, and outcome in patients either in ARDS or in at risk for ARDS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European Consensus Conference onARDS Definitions, Mechanisms, Relevant Outcomes, and Clinical Trial Coordination. Am J Respir Crit Care Med. 1994, 149: 818-824.CrossRefPubMed Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European Consensus Conference onARDS Definitions, Mechanisms, Relevant Outcomes, and Clinical Trial Coordination. Am J Respir Crit Care Med. 1994, 149: 818-824.CrossRefPubMed
2.
go back to reference Fowler AA, Hamman RF, Good JT, Benson KN, Baird M, Eberle DJ, Petty TL, Hyers TM: Adult respiratory distress syndrome risk with common predispositions. Ann Intern Med. 1983, 98: 593-597.CrossRefPubMed Fowler AA, Hamman RF, Good JT, Benson KN, Baird M, Eberle DJ, Petty TL, Hyers TM: Adult respiratory distress syndrome risk with common predispositions. Ann Intern Med. 1983, 98: 593-597.CrossRefPubMed
3.
go back to reference Rinaldo JE., Christman JW: Mechanisms and Mediators of the adult respiratory distress syndrome. Clin Chest Med. 1990, 11: 621-629.PubMed Rinaldo JE., Christman JW: Mechanisms and Mediators of the adult respiratory distress syndrome. Clin Chest Med. 1990, 11: 621-629.PubMed
4.
go back to reference Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ: Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982, 144: 124-128. 10.1016/0002-9610(82)90612-2.CrossRefPubMed Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ: Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982, 144: 124-128. 10.1016/0002-9610(82)90612-2.CrossRefPubMed
5.
go back to reference Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR: Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996, 154: 602-611.CrossRefPubMed Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR: Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996, 154: 602-611.CrossRefPubMed
7.
go back to reference Tomashefski JF: Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med. 2000, 21: 435-466.CrossRefPubMed Tomashefski JF: Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med. 2000, 21: 435-466.CrossRefPubMed
8.
go back to reference Meduri GU, Kanangat S, Stefan J, Tolley E, Schaberg D: Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria. Am J Respir Crit Care Med. 1999, 160: 961-967.CrossRefPubMed Meduri GU, Kanangat S, Stefan J, Tolley E, Schaberg D: Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria. Am J Respir Crit Care Med. 1999, 160: 961-967.CrossRefPubMed
9.
go back to reference Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR: Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001, 164: 1896-1903.CrossRefPubMed Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR: Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001, 164: 1896-1903.CrossRefPubMed
10.
go back to reference Tamura DY, Moore EE, Partrick DA, Johnson JL, Zallen G, Silliman CC: IL-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res. 1998, 76: 91-94. 10.1006/jsre.1998.5295.CrossRefPubMed Tamura DY, Moore EE, Partrick DA, Johnson JL, Zallen G, Silliman CC: IL-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res. 1998, 76: 91-94. 10.1006/jsre.1998.5295.CrossRefPubMed
11.
go back to reference Kiehl MG, Ostermann H, Thomas M, Muller C, Cassens U, Kienast J: Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome. Crit Care Med. 1998, 26: 1194-1199. 10.1097/00003246-199807000-00019.CrossRefPubMed Kiehl MG, Ostermann H, Thomas M, Muller C, Cassens U, Kienast J: Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome. Crit Care Med. 1998, 26: 1194-1199. 10.1097/00003246-199807000-00019.CrossRefPubMed
12.
go back to reference Martin TR: Lung cytokines and ARDS: Roger S. Mitchell Lecture. Chest. 1999, 116: 2S-8S. 10.1378/chest.116.suppl_1.2S.CrossRefPubMed Martin TR: Lung cytokines and ARDS: Roger S. Mitchell Lecture. Chest. 1999, 116: 2S-8S. 10.1378/chest.116.suppl_1.2S.CrossRefPubMed
13.
go back to reference Mulligan SM, Jones ML, Vaporciyan AA, Maureen CH, Ward PA: Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol. 1993, 151: 5666-5674.PubMed Mulligan SM, Jones ML, Vaporciyan AA, Maureen CH, Ward PA: Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol. 1993, 151: 5666-5674.PubMed
14.
go back to reference Van Laetherm JL, Eskinazi R, Louis H, Rickaert F, Robberecht P, Devieve J: Multisystem production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut. 1998, 43: 408-413.CrossRef Van Laetherm JL, Eskinazi R, Louis H, Rickaert F, Robberecht P, Devieve J: Multisystem production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut. 1998, 43: 408-413.CrossRef
15.
go back to reference Headley AS, Tolley E, Meduri GU: Infections and the inflammatory response in acute respiratory distress syndrome. Chest. 1997, 111: 1306-21.CrossRefPubMed Headley AS, Tolley E, Meduri GU: Infections and the inflammatory response in acute respiratory distress syndrome. Chest. 1997, 111: 1306-21.CrossRefPubMed
16.
go back to reference Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest. 1995, 108: 1303-14.CrossRefPubMed Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest. 1995, 108: 1303-14.CrossRefPubMed
17.
go back to reference Schutte H, Lohmeyer J, Rosseau S, Ziegler S, Siebert C, Kielisch H, Pralle H, Grimminger F, Morr H, Seeger W: Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J. 1996, 9: 1858-67. 10.1183/09031936.96.09091858.CrossRefPubMed Schutte H, Lohmeyer J, Rosseau S, Ziegler S, Siebert C, Kielisch H, Pralle H, Grimminger F, Morr H, Seeger W: Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J. 1996, 9: 1858-67. 10.1183/09031936.96.09091858.CrossRefPubMed
18.
go back to reference Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M: Prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. EPIC International Advisory Committee. JAMA. 1995, 274: 639-644. 10.1001/jama.274.8.639.CrossRefPubMed Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M: Prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. EPIC International Advisory Committee. JAMA. 1995, 274: 639-644. 10.1001/jama.274.8.639.CrossRefPubMed
19.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: The ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992, 101: 1644-1655.CrossRefPubMed Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: The ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992, 101: 1644-1655.CrossRefPubMed
20.
go back to reference Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med. 1985, 13: 818-29.CrossRefPubMed Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med. 1985, 13: 818-29.CrossRefPubMed
21.
go back to reference Baldwin DR, Wise R, Andrews JM, Honeybourne D: Microlavage: a technique for determining the volume of epithelial lining fluid. Thorax. 1991, 46: 658-662.CrossRefPubMedPubMedCentral Baldwin DR, Wise R, Andrews JM, Honeybourne D: Microlavage: a technique for determining the volume of epithelial lining fluid. Thorax. 1991, 46: 658-662.CrossRefPubMedPubMedCentral
22.
go back to reference Grassi J, Frobert Y, Pradelles P, Chercuitte F, Gruaz D, Dayer JM, Poubelle PE: Production of monoclonal antibodies against IL-1a and IL-1b: development of the two-enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media. J Immunol Meth. 1989, 123: 193-210. 10.1016/0022-1759(89)90223-8.CrossRef Grassi J, Frobert Y, Pradelles P, Chercuitte F, Gruaz D, Dayer JM, Poubelle PE: Production of monoclonal antibodies against IL-1a and IL-1b: development of the two-enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media. J Immunol Meth. 1989, 123: 193-210. 10.1016/0022-1759(89)90223-8.CrossRef
23.
go back to reference Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993, 39: 561-77.PubMed Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993, 39: 561-77.PubMed
24.
go back to reference Mitchell RS: Lung cytokines and ARDS. Chest. 1999, 116: 2S-8S. 10.1378/chest.116.suppl_1.2S.CrossRef Mitchell RS: Lung cytokines and ARDS. Chest. 1999, 116: 2S-8S. 10.1378/chest.116.suppl_1.2S.CrossRef
25.
go back to reference Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, Leeper K: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest. 1995, 107: 1062-1073.CrossRefPubMed Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, Leeper K: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest. 1995, 107: 1062-1073.CrossRefPubMed
26.
go back to reference Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP: High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med. 1991, 91: 23-29. 10.1016/0002-9343(91)90069-A.CrossRefPubMed Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP: High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med. 1991, 91: 23-29. 10.1016/0002-9343(91)90069-A.CrossRefPubMed
27.
go back to reference Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, Weiner-Kronish JP, Sticherling M, Christophers E, Matthay MA: Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis. 1992, 146: 427-432.CrossRefPubMed Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, Weiner-Kronish JP, Sticherling M, Christophers E, Matthay MA: Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis. 1992, 146: 427-432.CrossRefPubMed
28.
go back to reference Donnelly SC, Strieter RM, Reid PT, Kunkel SL, Burdick MD, Armstrong I, Mackenzie A, Haslett C: The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med. 1996, 125: 191-196.CrossRefPubMed Donnelly SC, Strieter RM, Reid PT, Kunkel SL, Burdick MD, Armstrong I, Mackenzie A, Haslett C: The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med. 1996, 125: 191-196.CrossRefPubMed
29.
go back to reference Parsons PE, Moss M, Vannice JL, Moore EE, Moore FA, Repine JE: Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at risk patients. Am J Respir Crit Care Med. 1997, 155: 1469-1473.CrossRefPubMed Parsons PE, Moss M, Vannice JL, Moore EE, Moore FA, Repine JE: Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at risk patients. Am J Respir Crit Care Med. 1997, 155: 1469-1473.CrossRefPubMed
30.
go back to reference Shelhamer JH, Levine SJ, Wu T, Jacoby DB, Kaliner MA, Rennard SI: Airway inflammation. Ann Intern Med. 1995, 123: 288-304.CrossRefPubMed Shelhamer JH, Levine SJ, Wu T, Jacoby DB, Kaliner MA, Rennard SI: Airway inflammation. Ann Intern Med. 1995, 123: 288-304.CrossRefPubMed
31.
go back to reference Agouridakis P, Kyriakou D, Alexandrakis MG, Prekates A, Perisinakis K, Karkavitsas N, Bouros D: The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res. 2002, 23 (3(1)): 25-10.1186/rr193.CrossRef Agouridakis P, Kyriakou D, Alexandrakis MG, Prekates A, Perisinakis K, Karkavitsas N, Bouros D: The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res. 2002, 23 (3(1)): 25-10.1186/rr193.CrossRef
32.
go back to reference Agouridakis P, Kyriakou D, Alexandrakis MG, Persinakis K, Karkavitsas N, Bouros D: Association between increased levels of IL-2 and IL-15 and outcome in patients with early acute respiratory distress syndrome. Eur J Clin Invest. 2002, 32: 862-867. 10.1046/j.1365-2362.2002.01081.x.CrossRefPubMed Agouridakis P, Kyriakou D, Alexandrakis MG, Persinakis K, Karkavitsas N, Bouros D: Association between increased levels of IL-2 and IL-15 and outcome in patients with early acute respiratory distress syndrome. Eur J Clin Invest. 2002, 32: 862-867. 10.1046/j.1365-2362.2002.01081.x.CrossRefPubMed
33.
go back to reference Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A: Inflammatory cytokines in the BAL of patients with ARDS. Chest. 1995, 108: 1303-1314.CrossRefPubMed Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A: Inflammatory cytokines in the BAL of patients with ARDS. Chest. 1995, 108: 1303-1314.CrossRefPubMed
34.
go back to reference Kiehl MG, Ostermann H, Thomas M, Muller T, Cassens U, Kienast J: Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acite respiratory distress syndrome. Crit Care Med. 1998, 26: 1194-1198. 10.1097/00003246-199807000-00019.CrossRefPubMed Kiehl MG, Ostermann H, Thomas M, Muller T, Cassens U, Kienast J: Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acite respiratory distress syndrome. Crit Care Med. 1998, 26: 1194-1198. 10.1097/00003246-199807000-00019.CrossRefPubMed
35.
go back to reference Donnelly SC, Strieter RM, Reid PT, Kunkel SL, Burdick MD, Armstrong I, Mackenzie A, Haslett C: The association between mortality rates and decreased concentrations of IL-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med. 1996, 125: 191-196.CrossRefPubMed Donnelly SC, Strieter RM, Reid PT, Kunkel SL, Burdick MD, Armstrong I, Mackenzie A, Haslett C: The association between mortality rates and decreased concentrations of IL-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med. 1996, 125: 191-196.CrossRefPubMed
36.
go back to reference Armstrong L, Millar AB: Relative production of tumour necrosis factor alpha and interleukin in adult respiratory distress syndrome. Thorax. 1997, 52: 442-446.CrossRefPubMedPubMedCentral Armstrong L, Millar AB: Relative production of tumour necrosis factor alpha and interleukin in adult respiratory distress syndrome. Thorax. 1997, 52: 442-446.CrossRefPubMedPubMedCentral
37.
go back to reference Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR: Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001, 164: 1896-1903.CrossRefPubMed Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR: Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001, 164: 1896-1903.CrossRefPubMed
Metadata
Title
The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome
Authors
Demosthenes Bouros
Michael G Alexandrakis
Katerina M Antoniou
Panagiotis Agouridakis
Ioannis Pneumatikos
Stavros Anevlavis
Athanasia Pataka
George Patlakas
Nikolaos Karkavitsas
Despina Kyriakou
Publication date
01-12-2004
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2004
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-4-6

Other articles of this Issue 1/2004

BMC Pulmonary Medicine 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine